GRO Biosciences is a Biotech company based in Cambridge, Massachusetts. It has raised $91M in total funding. Latest round: Series B.
GRO Biosciences is a Biotech company based in Cambridge, Massachusetts. GRO Biosciences has raised $91M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in July 2024. The round record for GRO Biosciences runs through 2024; nothing later has been disclosed. Investors on record include Atlas Venture, Access Biotechnology, Leaps by Bayer, Redmile Group, Digitalis Ventures, Innovation Endeavors and 3 others. 9 distinct backers are named across the disclosed rounds.
Totals shown for GRO Biosciences aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Cambridge and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026